HPTN Publications

Kumarasamy N, Flanigan TP, Mahajan AP, Carpenter CC, Mayer KH, Solomon S . Monitoring HIV treatment in the developing world. Lancet Infect Dis. 2002, 2: 656-7
Kumarasamy N, Mahajan AP, Flanigan TP, Hemalatha R, Mayer KH, Carpenter CCJ, Thyagarajan SP, Solomon S . Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr. 2002, 31: 378-83
Kumarasamy N, Solomon S, Chaguturu SK, Mahajan AP, Flanigan TP, Balakrishnan P, Mayer KH . The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India. AIDS. 2003, 17: 2267-9
Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH . Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis. 2003, 36: 79-85
Kumarasamy N, Vallabhaneni S, Cecelia AJ, Yepthomi T, Balakrishnan P, Saghayam S, Flanigan TP, Carpenter CC, Solomon S, Mayer KH . Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India. J Acquir Immune Defic Syndr. 2006, 41: 53-8 PMID: 16340473
Kumwenda N, Hoffman I, Chirenje M, Kelly C, Coletti A, Ristow A, Martinson F, Brown J, Chilongozi D, Richardson B, Rosenberg Z, Padian N, Taha T . HIV incidence among women of reproductive age in Malawi and Zimbabwe. Sex Transm Dis. 2006, 33: 646-51 PMID: 16773032
Kumwenda NI, Taha TE, Hoover DR, Markakis D, Liomba GN, Chiphangwi JD, Celentano DD . HIV-1 incidence among male workers at a sugar estate in rural Malawi. J Acquir Immune Defic Syndr. 2001, 27: 202-8
Kumwenda NI, Taha TE, Hoover DR, Markakis D, Liomba GN, Chiphangwi JD, Celentano DD . Three Surveys of HIV-1 Prevalence and Risk Factors Among Men Working at a Sugar Estate in Malawi. Sex Transm Dis. 2002, 29: 366-371
Kuo I, Golin CE, Wang J, Haley DF, Hughes J, Mannheimer S, Justman J, Rompalo A, Frew PM, Adimora AA, Soto-Torres L, Hodder S; HPTN 064 Study Team, Hodder S, HPTN 064 Study Team . Substance use patterns and factors associated with changes over time in a cohort of heterosexual women at risk for HIV acquisition in the United States. Drug Alcohol Depend. 2014, 139: 93-9
Kurth AE, Celum C, Baeten JM, Vermund SH, Wasserheit JN . Combination HIV Prevention: Significance, Challenges, and Opportunities. Curr HIV/AIDS Rep. 2011, 8: 62-72
Kurth AE, Mayer K, Beauchamp G, McKinstry L, Farrior J, Buchacz K, Donnell D, Branson B, El-Sadr W; HPTN (065) TLC-Plus Study Team . Clinician practices and attitudes regarding early antiretroviral therapy in the United States. J Acquir Immune Defic Syndr. 2012, 61: e65-9
Lade JM, To EE, Hendrix CW, Bumpus NN . Discovery of Genetic Variants of the Kinases That Activate Tenofovir in a Compartment-specific Manner. EBioMedicine. 2015, 2: 1145-52
Laeyendecker O, Brookmeyer R, Cousins MM, Mullis CE, Konikoff J, Donnell D, Celum C, Buchbinder SP, Seage GR 3rd, Kirk GD, Mehta SH, Astemborski J, Jacobson LP, Margolick JB, Brown J, Quinn TC, Eshleman SH . HIV incidence determination in the United States: A multi-assay approach. J Infect Dis. 2013, 207: 232-9
Laeyendecker O, Brookmeyer R, Mullis CE, Donnell D, Lingappa J, Celum C, Baeten JM, Campbell MS, Essex M, de Bruyn G, Farquhar C, Quinn TC, Eshleman SH; for the Partners in Prevention HSV/HIV Transmission Study Team . Specificity of four laboratory approaches for cross-sectional HIV incidence determination: Analysis of samples from adults with known nonrecent HIV infection from five African countries. AIDS Res Hum Retroviruses. 2012, 28: 1177-83
Laeyendecker O, Brookmeyer R, Oliver AE, Mullis CE, Eaton KP, Mueller AC, Jacobson LP, Margolick JB, Brown J, Rinaldo CR, Quinn TC, Eshleman SH . Multicenter AIDS Cohort Study (MACS). Factors associated with incorrect identification of recent HIV infection using the BED capture immunoassay. AIDS Res Hum Retroviruses. 2012, 28: 816-22
Laeyendecker O, Church JD, Oliver AE, Mwatha A, Owen SM, Donnell D, Brookmeyer R, Musoke P, Jackson JB, Guay L, Nakabiito C, Quinn TC, Eshleman SH . Pregnancy does not affect HIV incidence test results obtained using the BED capture enzyme immunoassay or an antibody avidity assay. PLoS One. 2010, 5: e 13259
Laeyendecker O, Konikoff J, Morrison DE, Brookmeyer R, Wang J, Celum C, Morrison CS, Abdool Karim Q, Pettifor AE, Eshleman SH . Identification and validation of a multi-assay algorithm for cross-sectional HIV incidence estimation in populations with subtype C infection. J Int AIDS Soc. 2018, 21
Laeyendecker O, Latimore A, Eshleman SH, Summerton J, Oliver AE, Gamiel J, Dobbs T, Mei J, Murphy G, Parry JV, Owen SM, Quinn TC . The effect of sample handling on cross sectional HIV incidence testing results. PLoS One. 2011, 6: e25899
Laeyendecker O, Piwowar-Manning E, Fiamma A, Kulich M, Donnell D, Bassuk D, Mullis CE, Chin C, Swanson P, Hackett J Jr, et al . Estimation of HIV incidence in a large, community-based, randomized clinical trial: NIMH project accept (HIV Prevention Trials Network 043). PLoS One. 2013, 8: e68349
Laeyendecker O, Redd AD, Nason M, Longosz AF, Karim QA, Naranbhai V, Garrett N, Eshleman SH, Abdool Karim SS, Quinn TC . Antibody Maturation in Women Who Acquire HIV Infection While Using Antiretroviral Preexposure Prophylaxis. J Infect Dis. 2015, 212: 754-9
Laeyendecker O, Rothman RE, Henson C, Horne BJ, Ketlogetswe KS, Kraus CK, Shahan J, Kelen GD, Quinn TC . The effect of viral suppression on cross-sectional incidence testing in the Johns Hopkins hospital emergency department. J Acquir Immune Defic Syndr. 2008, 48: 211-215
Lai S, Chen J, Celentano D, Page JB, Lai H, Yang J, Liu W, McCoy CB, Yu XF . Adoption of injection practices in heroin users in Guangxi Province, China. J Psychoactive Drugs. 2000, 32: 285-92
Lancaster KE, Hoffman IF, Hanscom B, Ha TV, Dumchev K, Susami H, Rose S, Go VF, Reifeis SA, Mollan KR, Hudgens MG, Piwowar-Manning EM, Richardson P, Dvoriak S, Djoerban Z, Kiriazova T, Zeziulin O, Djauzi S, Ahn CV, Latkin C, Metzger D, Burns DN, Sugarman J, Strathdee SA, Eshleman SH, Clarke W, Donnell D, Emel L, Sunner LE, McKinstry L, Sista N, Hamilton EL, Lucas JP, Duong BD, Van Vuong N, Sarasvita R, Miller WC, HPTN 074 Study Team . Regional differences between people who inject drugs in an HIV prevention trial integrating treatment and prevention (HPTN 074): a baseline analysis. J Int AIDS Soc. 2018, 21: e25195
Lancaster KE, Miller WC, Kiriazova T, Sarasvita R, Bui Q, Ha TV, Dumchev K, Susami H, Hamilton EL, Rose S, Hershow RB, Go VF, Metzger D, Hoffman IF, Latkin CA . Designing an Individually Tailored Multilevel Intervention to Increase Engagement in HIV and Substance Use Treatment Among People Who Inject Drugs With HIV: HPTN 074. AIDS Educ Prev. 2019, 31: 95-110
Landovitz RJ, Li S, Grinsztejn B, Dawood H, Liu AY, Magnus M, Hosseinipour MC, Panchia R, Cottle L, Chau G, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Zhang Y, Tolley E, Sugarman J, Kofron R, Adeyeye A, Burns D, Rinehart AR, Margolis D, Spreen WR, Cohen MS, McCauley M, Eron JJ . Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS Med. 2018, 15: e1002690
Landovitz RJ, Zangeneh SZ, Chau G, Grinsztejn B, Eron JJ, Dawood H, Liu AY, Panchia R, Hosseinipour MC, Kofron R, Margolis DA, Rinehart A, Adeyeye A, Burns D, McCauley M, Cohen MS, Currier JS . Cabotegravir is Not Associated with Weight Gain in HIV-uninfected Individuals in HPTN 077. Clin Infect Dis. 2019
Latkin C, Donnell D, Celentano DD, Aramrattna A, Liu TY, Vongchak T, Wiboonnatakul K, Davis-Vogel A, Metzger D . Relationships between social norms, social network characteristics, and HIV risk behaviors in Thailand and the United States. Health Psychol. 2009, 28: 323-9
Latkin C1, Donnell D, Liu TY, Davey-Rothwell M, Celentano D, Metzger D, Latkin C . The dynamic relationship between social norms and behaviors: the results of an HIV prevention network intervention for injection drug users. Addiction. 2013, 108: 934-43
Latkin CA, Donnell D, Metzger D, Sherman S, Aramrattna A, Davis-Vogel A, Quan VM, Gandham S, Vongchak T, Perdue T, Celentano DD . The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USA. Soci Sci Med. 2009, 68: 740-8
Latkin CA, Van Tieu H, Fields S, Hanscom BS, Connor M, Hanscom B, Hussen SA, Scott HM, Mimiaga MJ, Wilton L, Magnus M, Chen I, Koblin BA . Social Network Factors as Correlates and Predictors of High Depressive Symptoms Among Black Men Who Have Sex with Men in HPTN 061. AIDS Behav. 2017, 21: 1163-1170
Leddy AM, Lippman SA, Neilands TB, Twine R, Ahern J, Gomez-Olive FX, DeLong SM, MacPhail C, Kahn K, Pettifor AE . Community collective efficacy is associated with reduced physical intimate partner violence (IPV) incidence in the rural province of Mpumalanga, South Africa: findings from HPTN 068. J Epidemiol Community Health. 2019, 73: 176-181
Lee EJ, Kantor R, Zijenah L, Sheldon W, Emel L, Mateta P, Johnston E, Wells J, Shetty AK, Coovadia H, Maldonado Y, Adeniyi Jones S, Mofenson L, Contag CH, Bassett M, Katzenstein DA . Breast-milk shedding of drug-resistant HIV-1 Subtype C in women exposed to single-dose nevirapine. J Infect Dis. 2005, 192: 1260-4
Levy ME, Phillips G 2nd, Magnus M, Kuo I, Beauchamp G, Emel L, Hucks-Ortiz C, Hamilton EL, Wilton L, Chen I, Mannheimer S, Tieu HV, Scott H, Fields SD, Del Rio C, Shoptaw S, Mayer K . A Longitudinal Analysis of Treatment Optimism and HIV Acquisition and Transmission Risk Behaviors Among Black Men Who Have Sex with Men in HPTN 061. AIDS and Behavior. 2017, 21: 2958-2972
Lewis MK, Hsieh YH, Gaydos CA, Peterson SC, Rothman RE . Informed consent for opt-in HIV testing via tablet kiosk: an assessment of patient comprehension and acceptability. Int J STD AIDS. 2017, 28: 1292-1298
Lidström J, Li Q, Hoover DR, Kafulafula G, Mofenson LM, Fowler MG, Thigpen MC, Kumwenda N, Taha TE, Eshleman SH . Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero. AIDS. 2010, 24: 381-6
Lippman SA, Leddy AM, Neilands TB, Ahern J, MacPhail C, Wagner RG, Peacock D, Twine R, Goin DE, Gomez-Olive FX, Selin A, Tollman SM, Kahn K, Pettifor A . Village community mobilization is associated with reduced HIV incidence in young South African women participating in the HPTN 068 study cohort. J Int AIDS Soc. 2018, 21 Suppl 7: e25182
Liu W, Chen J, Rodolph M, Beauchamp G, Masse B, Wang S, Li R, Ruan Y, Zhou F, Leung MK, Lai S, Shao Y, Jackson JB . HIV prevalence among injection drug users in rural Guangxi China. Addiction. 2006, 101: 1493-8 PMID: 16968351
Lole K, Bollinger RC, Paranjape R, Gadkari D, Kulkarni S, Novak N, Ingersoll R, Sheppard H, Rau S . Full-length human immunodeficiency virus type 1 genomes from subtype c-infected seroconverters in India, with evidence of intersubtype recombination. J Virol. 1999, 73: 152-160
London AJ, Borasky DA Jr, Bhan A for the Ethics Working Group of the HIV Prevention Trials Network . Improving Ethical Review of Research Involving Incentives for Health Promotion. PLoS Med. 2012, 9: e1001193
London AJ, Borasky DA Jr, Bhan A; Ethics Working Group of the HIV Prevention Trials Network, Bhan A, Ethics Working Group of the HIV Prevention Trials Network . Improving ethical review of research involving incentives for health promotion. PLoS Med. 2012, 9: e1001193
Longosz AF, Mehta S, Kirk GD, Margolick JB, Brown J, Quinn TC, Eshleman SH, Laeyendecker O . Incorrect identification of recent HIV infection in adults in the United States using a limiting-antigen avidity assay. AIDS. 2014, 28: 1227-32
Longosz AF, Morrison CS, Chen P-L, Arts E, Nankya I, Salata RA, Franco V, Quinn TC, Eshleman SH, Laeyendecker O, Chen PL . Immune responses in Ugandan women infected with subtypes A and D HIV using the BED capture immunoassay and an antibody avidity assay. J Acquir Immune Defic Syndr. 2014, 65: 390-6
Longosz AF, Morrison CS, Chen PL, Brand HH, Arts E, Nankya I, Salata RA, Quinn TC, Eshleman SH, Laeyendecker O . Comparison of antibody responses to HIV infection in Ugandan women infected with HIV subtypes A and D. AIDS Res Hum Retroviruses. 2015, 31: 421-7
Longosz AF, Serwadda D, Nalugoda F, Kigozi G, Franco V, Gray RH, Quinn TC, Eshleman SH, Laeyendecker O . Impact of HIV subtype on performance of the limiting antigen-avidity enzyme immunoassay, the bio-rad avidity assay, and the BED capture immunoassay in Rakai, Uganda. AIDS Res Hum Retroviruses. 2014, 30: 339-44
Lu Y, Celum C, Wald A, Baeten JM, Cowan F, Delany-Moretlwe S, Reid SE, Hughes JP, Wilcox E, Corey L, Hendrix CW . Acyclovir achieves a lower concentration in African HIV-seronegative, herpes simplex virus 2-seropositive women than in non-African populations. Antimicrob Agents Chemother. 2012, 56: 2777-9
Lucas GM, Beauchamp G, Aramrattana A, Shao Y, Liu W, Fu L, Jackson JB, Celentano DD, Richardson P, Metzger D; for the HPTN 058 study group . Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058. Int J Drug Policy. 2012, 23: 162-5
Lucas GM, Young A, Donnell D, Richardson P, Aramrattana A, Shao Y, Ruan Y, Liu W, Fu L, Ma J, Celantano D, Metzger D, Jackson JB, Burns D, HPTN 058 study group . Hepatotoxicity in a 52-week randomized trial of short-term versus long-term treatment with buprenorphine/naloxone in HIV-negative injection opioid users in China and Thailand. Drug Alcohol Depend. 2014, 142: 139-45
Lynch BA, Patel EU, Courtney CR, Nanfack AJ, Bimela J, Wang X, Eid I, Quinn TC, Laeyendecker O, Nyambi PN, Duerr R, Redd AD . Short Communication: False Recent Ratio of the Limiting-Antigen Avidity Assay and Viral Load Testing Algorithm Among Cameroonians with Long-Term HIV Infection. AIDS Res Hum Retroviruses. 2017, 33: 1114-1116
Lynch KL, Breaud AR, Vandenberghe H, Wu AH, Clarke W . Performance evaluation of three liquid chromatography mass spectrometry methods for broad spectrum drug screening. Clin Chim Acta. 2010, 411: 1474-81
Machekano R, McFarland W, Hudes E, Bassett MT, Mbizvo MT, Katzenstein D . Correlates of HIV test results seeking and utilization of partner counseling services in a corhort of male factory workers in Zimbabwe. AIDS Behav. 2000, 4: 63-70
Machekano R, McFarland W, Mbizvo MT, Bassett MT, Katzenstein D, Latif AS . Impact of HIV counselling and testing on HIV seroconversion and reported STD incidence among male factory workers in Harare, Zimbabwe. Central Af J Med. 1998, 44: 98-102
Machekano RN, Bassett MT, Zhou PS, Mbizvo MT, Latif AS, Katzenstein DA . Report of sexually transmitted diseases by HIV infected men during follow up: time to target the infected?. Sex Transm Infect. 2000, 76: 188-92
MacPhail C, Khoza N, Selin A, Julien A, Twine R, Wagner RG, Gomez-Olive X, Kahn K, Wang J, Pettifor A . Cash transfers for HIV prevention: what do young women spend it on? Mixed methods findings from HPTN 068.. BMC Public Health. 2017, 18: 10
MacQueen K, Alleman P . International Perspectives on the Collection, Storage, and Testing of Human Biospecimens in HIV Research. IRB: Ethics and Human Research. 2008, 30: 9-14 PMID:18767319
MacQueen KM, Abdool Karim Q, Sugarman J . Ethics guidance for HIV prevention trials. BMJ. 2003, 327: 340
Macqueen KM, McLoughlin K, Alleman P, Burke HM, Mack N . Partnering for Care in HIV Prevention Trials. J Empir Res Hum Res Ethics. 2008, 3: 5-18 PMID:19385753
Macqueen KM, Namey E, Chilongozi DA, Mtweve SP, Mlingo M, Morar N, Reid C, Ristow A, Sahay S, HPTN 035 Standard of Care Assessment Team . Community perspectives on care options for HIV prevention trial participants. AIDS Care. 2007, 19: 554-60 PMID:17453597
MacQueen KM, Sugarman J . Back to the Rough Ground: Working in International HIV Prevention Research as Ethical Debates Continue. IRB: Ethics and Human Research. 2003, 25: 11-13
MacRegga Severe, Joy D. Scheidell, Typhanye V. Dyer, Russell A. Brewer, Alberta Negri, Rodman E. Turpin, Kailyn E. Young, Christopher Hucks-Ortiz, Charles M. Cleland, Kenneth Mayer, Maria R. Khan . Lifetime Burden of Incarceration and Violence, Internalized Homophobia, and HIV/STI Risk among Black Men who Have Sex with Men in the HPTN 061 Study. AIDS Behavior. 2020
Magidson JF, Li X, Mimiaga MJ, Moore AT, Srithanaviboonchai K, Friedman RK, Limbada M, Hughes JP, Cummings V, Gaydos CA, Elharrar V, Celentano D, Mayer KH, Safren SA . Antiretroviral Medication Adherence and Amplified HIV Transmission Risk Among Sexually Active HIV-Infected Individuals in Three Diverse International Settings. AIDS and Behavior. 2016, 20: 699-709
Magnus M, Franks J, Griffith S, Arnold MP, Goodman K, Wheeler DP; for the HPTN 061 Study Group, Wheeler DP, HPTN 061 Study Group . Engaging, Recruiting, and Retaining Black Men Who Have Sex With Men in Research Studies: Don't Underestimate the Importance of Staffing-Lessons Learned From HPTN 061, the BROTHERS Study. J Public Health Manag Pract. 2014, 20: E1-9
Mahajan AP, Hogan JW, Snyder B, Kumarasamy N, Mehta K, Solomon S, Carpenter CC, Mayer KH, Flanigan TP . Changes in Total Lymphocyte Count as a Surrogate for Changes in CD4 Count Following Initiation of HAART: Implications for Monitoring in Resource-Limited Settings. J Acquir Immune Defic Syndr. 2004, 36: 567-575
Mahiane SG, Laeyendecker O . Segmented polynomials for incidence rate estimation from prevalence data. Stat Med. 2017, 36: 334-344
Mahlokozera T, Kang HH, Goonetilleke N, Stacey AR, Lovingood RV, Denny TN, Kalilani L, Bunn JE, Meshnick SR, Borrow P, Letvin NL, Permar SR . The magnitude and kinetics of the mucosal HIV-specific CD8+ T lymphocyte response and virus RNA load in breast milk. PLoS One. 2011, 6: e23735
Maman S, Abler L, Parker L, Lane T, Chirowodza A, Ntogwisangu J, Srirak N, Modiba P, Murima O, Fritz K . A comparison of HIV stigma and discrimination in five international sites: the influence of care and treatment resources in high prevalence settings. Soc Sci Med. 2009, 68: 2271-8
Maman S, Lane T, Ntogwisangu J, Motholo T, Sikotoyi S, Visrutaratna S, Fritz K, Chitumba A . Using participatory mapping to inform the research and intervention design of a multi-site community-randomized trial of community-based HIV counseling and testing. Journal Field Methods. 2009, 21: 368-387 (Journal Field Methods is not a PMC Journal)
Maman S, van Rooyen H, Stankard P, Chingono A, Muravha T, Ntogwisangu J, Phakathi Z, Srirak N, Morin S; NIMH Project Accept (HPTN 043) study team . NIMH Project Accept (HPTN 043): results from in-depth interviews with a longitudinal cohort of community members. PLoS One. 2014, 9: e87091
Mannheimer S, Hirsch-Moverman Y, Franks J, Loquere A, Hughes JP, Li M, Amico KR, Grant RM . Factors Associated With Sex-Related Pre-exposure Prophylaxis Adherence Among Men Who Have Sex With Men in New York City in HPTN 067. J Acquir Immune Defic Syndr. 2019, 80: 551-558
Mannheimer S, Wang L, Wilton L, Tieu HV, Del Rio C, Buchbinder S, Fields S, Glick S, Conor MB, Cummings V, Eshleman SH, Koblin B, Mayer KH . Infrequent HIV Testing and Late HIV Diagnosis Are Common Among US Black Men Who Have Sex with Men (BMSM). J Acquir Immune Defic Syndr. 2014, 67: 438-45
Margolick JB, Bream JH, Martinez-Maza O, Lopez J, Li X, Phair JP, Koletar SL, Jacobson LP . Frailty and Circulating Markers of Inflammation in HIV+ and HIV- Men in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2017, 74: 407-417
Margolick JB, Bream JH, Nilles TL, Li H, Langan SJ, Deng S, Wang R, Wada N, Leng SX . Relationship Between T-Cell Responses to CMV, Markers of Inflammation, and Frailty in HIV-uninfected and HIV-infected Men in the Multicenter AIDS Cohort Study. J Infect Dis. 2018, 218: 249-258
Marmor M, Sheppard HW, Donnell D, Bozeman S, Celum C, Buchbinder S, Koblin B, Seage G . Homozygous and Heterozygous CCR5-32 Genotypes are Associated with Resistence to HIV infection. J Acquir Immune Defic Syndr. 2001, 27: 472-81
Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB . Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet. 1999, 354: 803-9
Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB . The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa. Ann N Y Acad Sci. 2000, 918: 53-6
Marzinke M, Breaud A, Parsons TL, Cohen MS, Piwowar-Manning E, Eshleman SH, Clarke W . The development and validation of a method using high-resolution mass spectrometry (HRMS) for the qualitative detection of antiretroviral agents in human blood. Clin Chim Acta. 2014, 10: 157-68
Marzinke MA, Clarke W, Wang L, Cummings V, Liu TY, Piwowar-Manning E, Breaud A, Griffith S, Buchbinder S, Shoptaw S, del Rio C, Magnus M, Mannheimer S, Fields SD, Mayer KH, Wheeler DP, Koblin BA, Eshleman SH, Fogel JM . Nondisclosure of HIV status in a clinical trial setting: antiretroviral drug screening can help distinguish between newly diagnosed and previously diagnosed HIV infection. Clin Infect Dis. 2014, 58: 117-20
Masemola A, Mashishi T, Khoury G, Mohube P, Mokgotho P, Vardas E, Colvin M, Zijenah L, Katzenstein D, Musonda R, Allen S, Kumwenda N, Taha T, Gray G, McIntyre J, Karim SA, Sheppard HW, Gray CM; HIVNET 028 Study Team . Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load. J Virol. 2004, 78: 3233-43
Masemola AM, Mashishi TN, Khoury G, Bredell H, Paximadis M, Mathebula T, Barkhan D, Puren A, Vardas E, Colvin M, Zijenah L, Katzenstein D, Musonda R, Allen S, Kumwenda N, Taha T, Gray G, McIntyre J, Karim SA, Sheppard HW, Gray CM; HIVNET 028 Study Team . Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from southern Africa. J Immunol. 2004, 173: 4607-17
Mastro TD, Kim AA, Hallett T, Rehle T, Welte A, Laeyendecker O, Oluoch T, Garcia-Calleja JM . Estimating HIV incidence in populations Using tests for recent Infection: Issues, challenges and the way forward. J HIV/AIDS Surv & Epidemiol. 2010, 2: 1-14
Mauck C, Rosenberg Z, Van Damme L . Recommendations for the clinical development of topical microbicides: an update. AIDS. 2001, 15: 857-68
Mayer K, Karim S, Kelly C, Maslankowski L, Rees H, Profy A, Day J, Welch J, Rosenberg Z . Safety and tolerability of vaginal PRO2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women. AIDS. 2003, 17: 321-9
Mayer K, Peipert J, Fleming T, Fullem A, Moench T, Cu-Uvin S, Bentley M, Chesney M, Rosenberg Z . Safety and tolerability of Buffergel, a novel vaginal microbicide, in women in the United States. Clin Infect Dis. 2001, 32: 476-82
Mayer KH, Kwong J, Singall R, Boswell S . Non-occupational post-exposure prophylaxis: Clinical issues and public health questions. Medicine and Health/Rhode Island. 2000, 83: 210-3
Mayer KH, Maslankowski LA, Gai F, El-Sadr WM, Justman J, Kwiecien A, Masse B, Eshleman SH, Hendrix C, Morrow K, Rooney JF, Soto-Torres L; HPTN 050 Protocol Team . Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS. 2006, 20: 543-51 PMID: 16470118
Mayer KH, Pizer HF . HIV Prevention: A Comprehensive Approach. London Academic Press. 2008, ISBN: 0123742358
Mayer KH, Venkatesh KK . Antiretroviral therapy as HIV prevention: status and prospects. Am J Public Health. 2010, 100: 1867-76
Mayer KH, Wang L, Koblin B, Mannheimer S, Magnus M, del Rio C, Buchbinder S, Wilton L, Cummings V, Watson CC, Piwowar-Manning E, Gaydos C, Eshleman SH, Clarke W, Liu TY, Mao C, Griffith S, Wheeler D; HPTN061 Protocol Team, Wheeler D, HPTN 061 Protocol Team . Concomitant socioeconomic, behavioral, and biological factors associated with the disproportionate HIV infection burden among Black men who have sex with men in 6 U.S. cities. PLoS One. 2014, 9: e87298
Mayer KH, Wheeler DP, Bekker LG, Grinsztejn B, Remien RH, Sandfort TG, Beyrer C . Overcoming biological, behavioral, and structural vulnerabilities: new directions in research to decrease HIV transmission in men who have sex with men. J Acquir Immune Defic Syndr. 2013, 63: S161-7
Mbeda C, Ogendo A, Lando R, Schnabel D, Gust DA, Guo X, Akelo V, Dominguez K, Panchia R, Mbilizi Y, Chen Y, Chege W, Sandfort TG . Healthcare-Related Stigma among Men Who Have Sex with Men and Transgender Women in Sub-Saharan Africa Participating in Hiv Prevention Trials Network Hptn 075 Study. AIDS Care. , 32: 1052-1060
McConnell MS, Stringer JS, Kourtis AP, Weidle PJ, and Eshleman SH . Use of single-dose nevirapine for the prevention of mother-to-child transmission of HIV-1: does development of resistance matter?. Am J Obstet Gynecol. 2007, 197: S56-S63 PMID: 17825651
McFarland W, Gwanzura L, Bassett MT, Machekano R, Latif AS, Le C, Parsonnet J, Burke RL, Katzenstein D . Prevalence and incidence of herpes simplex virus type 2 infection among male Zimbabwean factory workers. J Infect Dis. 1999, 180: 1459-65
McFarland W, Mvere D, Shamu R, Katzenstein D . Risk factors for HIV infection among first-time blood donors in Zimbabwe. Transfusion. 1998, 38: 279-84
McGowan I, Elliott J, Cortina G, Tanner K, Siboliban C, Adler A, Cho D, Boscardin WJ, Soto-Torres L, Anton PA . Characterization of baseline intestinal mucosal indices of injury and inflammation in men for use in rectal microbicide trials (HIV Prevention Trials Network-056). J Acquir Immune Defic Syndr. 2007, 46: 417-25 PMID: 17891044
McGowan I, Wilkin T, Landovitz RJ, Wu C, Chen Y, Marzinke MA, Hendrix CW, Richardson P, Eshleman SH, Andrade A, Chege W, Anderson PL, McCauley M, Farley J, Mayer KH, Anton P, Brand RM, Cranston RD, Gulick R . The pharmacokinetics, pharmacodynamics, and mucosal responses to maraviroc-containing pre-exposure prophylaxis regimens in MSM. AIDS. 2019, 33: 237-246